Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Litorina in connection with the acquisition of Brödernas
Mandate

Vinge has advised Litorina in connection with the acquisition of Brödernas

June 15, 2021 Employment and Benefits Intellectual Property M&A Environmental Law Real Estate and Construction Banking and Finance IT, Telecommunications and Outsourcing

Brödernas is a fast-growing restaurant chain focused on serving high-quality burger and pizza in Sweden.

Brödernas was founded in 2017 by the brothers Joakim and Jonas Wiklander and early 2019 the brothers Monir Kalgoum and Mika Zibanejad joined as owners. Brödernas has 34 restaurants in Sweden today and an ambitious plan to reach 60-70 restaurants in 2021. Thanks to the partnership, Brödernas can now continue their successful expansion in Sweden and internationally.

Vinge's team consisted of Jonas Johansson together with, among others, Carl Sander, Ellinor Wargenbrant and Gustav Lindgren (M&A), Frida Ställborn, Karolina Cohrs and Ulf Pyk (Real Estate), Lina Österberg (Environment), Seyran Sahin (Banking and Finance), Elin Broman and Ebba Svenburg (Employment), Isabell Nielsen and Alva Hägglund (Commercial Agreements), Felizia Wiker (IP), Mika Jordan (IT) and Sara Dahlros Sköld (VDR).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025